rs387907067

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM5PP3_StrongPP5_Very_Strong

The NM_018344.6(SLC29A3):​c.1087C>T​(p.Arg363Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R363Q) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

SLC29A3
NM_018344.6 missense

Scores

12
5
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 2.69

Publications

16 publications found
Variant links:
Genes affected
SLC29A3 (HGNC:23096): (solute carrier family 29 member 3) This gene encodes a nucleoside transporter. The encoded protein plays a role in cellular uptake of nucleosides, nucleobases, and their related analogs. Mutations in this gene have been associated with H syndrome, which is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism. A related disorder, PHID (pigmented hypertrichosis with insulin-dependent diabetes mellitus), has also been associated with mutations at this locus. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2010]
SLC29A3 Gene-Disease associations (from GenCC):
  • H syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • dysosteosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr10-71362268-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 30948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.959
PP5
Variant 10-71362267-C-T is Pathogenic according to our data. Variant chr10-71362267-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 30949.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC29A3NM_018344.6 linkc.1087C>T p.Arg363Trp missense_variant Exon 6 of 6 ENST00000373189.6 NP_060814.4 Q9BZD2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC29A3ENST00000373189.6 linkc.1087C>T p.Arg363Trp missense_variant Exon 6 of 6 1 NM_018344.6 ENSP00000362285.5 Q9BZD2-1

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152112
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000477
AC:
12
AN:
251422
AF XY:
0.0000294
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.0000116
AC:
17
AN:
1461884
Hom.:
0
Cov.:
34
AF XY:
0.00000825
AC XY:
6
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.000246
AC:
11
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1112012
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152112
Hom.:
0
Cov.:
32
AF XY:
0.0000673
AC XY:
5
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41422
American (AMR)
AF:
0.000327
AC:
5
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000370
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

H syndrome Pathogenic:3
Jan 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 363 of the SLC29A3 protein (p.Arg363Trp). This variant is present in population databases (rs387907067, gnomAD 0.02%). This missense change has been observed in individuals with H syndrome (PMID: 19889517, 27143505, 29041934; internal data). ClinVar contains an entry for this variant (Variation ID: 30949). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC29A3 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg363 amino acid residue in SLC29A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19889517, 21888995, 23530176, 27364927, 29808591; internal data). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Jan 01, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

May 12, 2015
Genetic Services Laboratory, University of Chicago
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SLC29A3-related disorder Pathogenic:1
Feb 16, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The SLC29A3 c.1087C>T variant is predicted to result in the amino acid substitution p.Arg363Trp. This variant was reported in the homozygous state in individuals with histiocytosis-lymphadenopathy plus syndrome, also known as H syndrome (Molho-Pessach et al. 2010. PubMed ID: 19889517; Bloom et al. 2017. PubMed ID: 29041934). This variant is reported in 0.020% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-73122024-C-T). Another missense variant affecting the same amino acid residue but resulting in a different substitution (p.Arg363Gln) was also reported in the homozygous state in individuals with H syndrome (Molho-Pessach et al. 2010. PubMed ID: 19889517; Jaouadi et al. 2018. PubMed ID: 29808591). Taken together, the c.1087C>T (p.Arg363Trp) variant is interpreted as likely pathogenic. -

not provided Pathogenic:1
Mar 13, 2025
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35284993, 19889517, 29041934, 27143505, 34426522, 34786169, 39412751, 37638031, 31192449, 38263041, 23530176, 29808591, 34657628, 35865784) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.27
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.52
D;D;.
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.97
.;D;D
M_CAP
Pathogenic
0.30
D
MetaRNN
Pathogenic
0.96
D;D;D
MetaSVM
Uncertain
0.34
D
MutationAssessor
Pathogenic
3.1
M;M;.
PhyloP100
2.7
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-7.4
.;D;.
REVEL
Pathogenic
0.83
Sift
Pathogenic
0.0
.;D;.
Polyphen
1.0
D;D;.
Vest4
0.98
MutPred
0.83
Gain of catalytic residue at D359 (P = 0.1669);Gain of catalytic residue at D359 (P = 0.1669);.;
MVP
0.89
MPC
0.39
ClinPred
0.95
D
GERP RS
5.6
Varity_R
0.92
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387907067; hg19: chr10-73122024; COSMIC: COSV64385198; COSMIC: COSV64385198; API